(Fig 9D) Methotrexate, Oxaliplatin, Topotecan, Dasatinib, Etoposide and Fluorouracil might be viewed as targeted drugs for the treatment of SCLC patients with high expression of BUB1B. The gene discussed is BUB1B; the disease is small cell lung carcinoma.